Naltrexon-Hcl Neuraxpharm (Naltrexone Hydrochloride)

Naltrexone hydrochloride, the active ingredient in Naltrexon-Hcl Neuraxpharm, is an opioid antagonist presented as an oral tablet for systemic use. It is indicated for the management of alcohol dependence and opioid dependence in adult patients, helping to reduce cravings and prevent relapse. The medication works by competitively blocking mu, kappa and delta opioid receptors, thereby diminishing the reinforcing effects of alcohol and opioids.

GNH USA supplies Naltrexon-Hcl Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Naltrexon-Hcl is an opioid antagonist used in the treatment of substance‑use disorders, particularly those involving alcohol and opioids.

- Alcohol dependence: reduces cravings and supports maintenance of abstinence. - Opioid dependence: blocks opioid receptors to prevent relapse after detoxification. - Substance use disorder (general): incorporated into comprehensive therapy to decrease reinforcement from addictive substances.

Naltrexon-Hcl may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Headache - Dizziness - Fatigue

Serious or Rare Side Effects: - Hepatotoxicity (elevated liver enzymes) - Severe depression or suicidal ideation - Allergic reactions such as rash or angioedema

Before initiating therapy, clinicians should evaluate several safety considerations. - Assess liver function: obtain baseline hepatic enzymes. - Monitor for depression: watch for worsening mood or suicidal thoughts. - Avoid in patients receiving opioid agonists: risk of precipitated withdrawal. - Use caution in renal impairment: adjust monitoring as needed. - Counsel women of childbearing potential: pregnancy safety is unknown. - Store at ambient temperature: keep in original container, protect from moisture.

Naltrexon-Hcl can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Opioid agonist analgesics (e.g., morphine, oxycodone) – may precipitate acute withdrawal. - Opioid‑containing anesthesia or sedation – risk of severe withdrawal.

Moderate Interactions (Monitor Closely): - Alcohol – may increase hepatotoxic risk. - Benzodiazepines – additive central nervous system depression. - Antidepressants (SSRIs, SNRIs) – monitor for mood changes.